CEA, Cyfra21‐1, and NSE were the most frequently detected, which increased slightly from around 50% in 2013 to around 78% in 2017 in NSCLC and from around 70% in 2013 to around 92% in 2017 in SCLC. Here, CEACAM5 is linked to non-small cell lung carcinoma.